Posted inNews and Updates
HHS Fast-Tracks Early Drug Research to Counter Global Rivals
The HHS is fast-tracking early-stage drug research to boost domestic innovation and counter global competition. Learn how this shift impacts biotech.
Posted inNews and Updates
HHS Launches Strategic Initiative to Bolster Clinical Trials
The HHS has unveiled a new national strategy to modernize clinical trials, focusing on decentralization, improved data sharing, and increased diversity.
Posted inNews and Updates
New Investigational Drug Shows Promise for Cholesterol Control
A new investigational drug from UC San Diego shows potential to improve cholesterol management, offering hope for patients with statin intolerance.
Posted inNews and Updates
Samsung Partners with Alcedis for Wearable Clinical Trials
Samsung and Alcedis are partnering to integrate wearable biometric data into clinical trials, advancing the use of real-world evidence in drug development.
Posted inNews and Updates
Samsung Partners with Alcedis to Enhance Clinical Trials
Samsung partners with Alcedis to bridge the gap between wearable health data and clinical trial evidence, enhancing remote monitoring and data accuracy.
Posted inNews and Updates
New Kidney Transplant Drug Outperforms Standard Therapy
A new clinical trial shows a promising drug outperforms standard treatments in preventing kidney transplant rejection. Read the latest on this breakthrough.
Posted inNews and Updates
Viking Therapeutics Launches Phase 1 Trial for Novel VK3019
Viking Therapeutics has launched a Phase 1 trial for VK3019, a novel amylin receptor agonist targeting metabolic disorders. Learn about this new development.
Posted inNews and Updates
FDA Clears Auxora for Continued KOURAGE Clinical Trials
The FDA has greenlit the continuation of the KOURAGE trial for Auxora. Learn how this CRAC channel inhibitor could change acute pancreatitis treatment.
Posted inNews and Updates
Ascletis Gains FDA Approval for Phase 1 Obesity Drug Trial
Ascletis Pharma receives FDA clearance for Phase I trials of ASC46, a novel oral GLP-1 agonist, marking a new advancement in obesity treatment research.
Posted inNews and Updates
Helus Pharma Updates Phase 3 APPROACH Trial Enrollment
Helus Pharma shares key progress on the Phase 3 APPROACH clinical trial. Learn about the latest enrollment milestones in this pivotal drug development study.